In the heart of the emergency room, when the nurse takes charge of the patient, he/she must be able to distinguish between an acute confusional syndrome and psychobehavioral symptoms related to neurocognitive disorders. Indeed, early identification of the confusional syndrome is essential to accelerate the implementation of non-drug measures by the nurse in order to reduce its duration and the induced complications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.revinf.2023.03.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pain-Induced Delirium in Patient with Dementia: A Case Report and Narrative Review.
J Pain Palliat Care Pharmacother
November 2024
Psychiatrist Consultant, Department of Psychiatry, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Pain management is the hallmark of palliative care; however, pain is commonly underassessed in cases of advanced dementia and delirium (acute confusional state). We present a case of a 66-year-old female patient with severe dementia who was hospitalized because of behavioral changes and sleep disturbance. Symptoms of confusion, disorientation, inattention, and agitation were most severe at night.
View Article and Find Full Text PDF[Diagnosis and management of delirium in older adults].
Rev Med Interne
November 2024
Clinical Gerontology Department, CHU of Nantes, Nantes, France.
Article Synopsis
- * It functions like "acute brain failure," often triggered by other health problems like infections or metabolic issues, and can have serious impacts on patients and the healthcare system.
- * The review focuses on diagnosing delirium in older adults, discussing available screening tools, exploring its relationship with dementia, and outlining both non-drug and drug management strategies for treatment.
Levetiracetam as an Alternative for Refractory Confusional Syndromes: A Case Series.
J Palliat Med
January 2025
Department of Palliative, Rehabilitation, & Integrative Medicine UT MD Anderson Cancer Center, Houston, Texas, USA.
[Hyperammoniemic encephalopathy: beyond the hepatic cause].
Rev Med Suisse
October 2024
Service de médecine interne générale, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.
Hyperammoniemic encephalopathy is part of the differential -diagnosis in the presence of an acute confusional state. Although associated with liver dysfunction in the majority of cases, it can be observed in many other clinical situations. Often not investigated, the dosage of ammonium in the blood should be integrated in the biological work-up of encephalopathy of unknown origin.
View Article and Find Full Text PDFA real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1).
Front Pharmacol
September 2024
Department of Pharmacy, The 305 Hospital of PLA, Beijing, China.
Article Synopsis
- The study investigates adverse events (AEs) associated with eslicarbazepine acetate (ESL), a medication approved in 2013 for partial-onset seizures, using data from the FDA Adverse Event Reporting System (FAERS).
- It employs various statistical methods to identify significant AE signals and examines demographic factors like gender and age related to these events.
- The analysis revealed 5,719 AE reports, with notable issues related to nervous system disorders occurring mostly within the first month of treatment, resulting in 86 significant positive signals.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!